All News

As an increasing emphasis continues to be placed on value and patient outcomes, drug makers are being presented with an opportunity to jockey for market share and brand differentiation by staying ahead of the curve when it comes to presenting outcomes data that correlates to therapies.

The UCLA Health System is working hard to establish a blueprint for reducing health care costs up to 30% over the next five years.

There still lacks evidence to support the theory that proton-beam therapy is more effective than traditional therapy when it comes to treating prostate cancer; however, it would be hard to deduce that fact based on the rapidly growing popularity of proton therapy centers.

Under the ideal of consumer-directed health care, patients are supposed to save money on premiums and shop for the best care at the lowest price.

Many primary care physicians - and even some oncologists - are unaware of common long-term side effects of four widely used breast and colorectal cancer drugs, a national survey by the National Cancer Institute reveals.

Rising prices meant higher health spending for patients with insurance through a job in 2010 even as demand for medical care stagnated, according to the first report generated from a trove of claims data from private insurers.